Ticker Details
KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
IPO Date:	April 9, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$981.42M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.40 | 2.93%
Avg Daily Range (30 D):	$0.60 | 3.20%
Avg Daily Range (90 D):	$0.63 | 2.62%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	.92M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	15
Avg Institutional Trade:	$3.06M
Avg Institutional Trade (30 D):	$3.06M
Avg Institutional Trade (90 D):	$3.06M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	15

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$2.11M
Avg Closing Trade (90 D):	$1.75M
Avg Closing Volume:	102.36K

News

May 14, 2026 @ 5:49 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

May 12, 2026 @ 3:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Conti... Source: Juan Monteverde, Monteverde & Associates Pc

Jan 9, 2026 @ 1:54 PM Stock Market Today: Dow, Nasdaq 100 And S&P 500 Fu... Source: Rishabh Mishra

Sep 11, 2025 @ 8:25 PM KalVista Posts 154% Expense Jump in Q1 Source: Motley Fool Markets Team

Aug 21, 2025 @ 6:24 PM Ionis Pharma Wins FDA Nod For First RNA-Targeted T... Source: Vandana Singh

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.43	$-.92
Diluted EPS		$-.43	$-.92
Revenue		$40.86M	$13.7M
Gross Profit		$37.77M	$12.47M
Net Income / Loss		$-23.49M	$-49.48M
Operating Income / Loss		$-23.44M	$-46.05M
Cost of Revenue		$3.09M	$1.23M
Net Cash Flow		$-13.89M
PE Ratio